$CNS
COHEN & STEERS, INC. Stock $cns

$cns Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000128481223000159 Filed on May 05, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$120.6M	$126.1M
YoY Change	-18.18%	-18.23%
Cost Of Revenue	$13.33M	$14.22M
YoY Change	-26.91%	-58.13%
Gross Profit	$107.3M	$111.9M
YoY Change	-16.95%	-6.96%
Gross Profit Margin	88.95%	88.72%
Selling, General & Admin	$65.62M	$65.98M
YoY Change	-2.2%	-3.33%
% of Gross Profit	61.16%	58.98%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$839.0K	$988.0K
YoY Change	-24.14%	-0.6%
% of Gross Profit	0.78%	0.88%
Operating Expenses	$66.46M	$66.97M
YoY Change	-23.11%	-35.11%
Operating Profit	$40.84M	$44.90M
YoY Change	-33.04%	-11.95%
Interest Expense	$3.784M	$2.908M
YoY Change	-114.18%	-34.86%
% of Operating Profit	9.27%	6.48%
Other Income/Expense, Net	-$1.134M	-$1.276M
YoY Change	-95.46%	-124.97%
Pretax Income	$43.49M	$46.53M
YoY Change	20.84%	-17.06%
Income Tax	$10.99M	$10.23M
% Of Pretax Income	25.26%	21.99%
Net Earnings	$31.78M	$35.31M
YoY Change	-38.84%	-15.96%
Net Earnings / Revenue	26.34%	28.01%
Basic Earnings Per Share	$0.64	$0.72
Diluted Earnings Per Share	$0.64	$0.71
COMMON SHARES
Basic Shares Outstanding	49.12M shares	49.10M shares
Diluted Shares Outstanding	49.46M shares	49.40M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$178.5M	$149.5M
YoY Change	41.01%	76.28%
Cash & Equivalents	$178.5M	$149.5M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$63.22M	$76.56M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$241.7M	$226.1M
YoY Change	19.48%	29.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$36.33M	$12.36M
YoY Change	333.51%	43.39%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$21.00K	$20.00K
YoY Change	0.0%	81.82%
Other Assets
YoY Change
Total Long-Term Assets	$383.3M	$397.3M
YoY Change	2.19%	-2.85%
TOTAL ASSETS
Total Short-Term Assets	$241.7M	$226.1M
Total Long-Term Assets	$383.3M	$397.3M
Total Assets	$625.0M	$623.4M
YoY Change	8.25%	6.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.257M	$1.223M
YoY Change	-79.12%	-97.33%
Accrued Expenses	$147.1M	$154.3M
YoY Change	132.29%	232.29%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$157.1M	$176.4M
YoY Change	81.04%	36.34%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$24.00M	$17.40M
YoY Change	57.64%	26.06%
Total Long-Term Liabilities	$24.00M	$17.40M
YoY Change	57.64%	26.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$157.1M	$176.4M
Total Long-Term Liabilities	$24.00M	$17.40M
Total Liabilities	$181.1M	$193.8M
YoY Change	77.55%	35.35%
SHAREHOLDERS EQUITY
Retained Earnings	-$162.2M	-$165.1M
YoY Change	-16.01%	-24.1%
Common Stock	$558.0K	$558.0K
YoY Change	1.45%	1.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$270.8M	$270.6M
YoY Change	8.7%	8.71%
Treasury Stock Shares		6.614M shares
Shareholders Equity	$353.2M	$337.0M
YoY Change
Total Liabilities & Shareholders Equity	$625.0M	$623.4M
YoY Change	8.25%	6.89%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	$31.78M	$35.31M
YoY Change	-38.84%	-15.96%
Depreciation, Depletion And Amortization	$839.0K	$988.0K
YoY Change	-24.14%	-0.6%
Cash From Operating Activities	$53.68M	-$14.97M
YoY Change	-6.93%	-85.94%
INVESTING ACTIVITIES
Capital Expenditures	$15.55M	$4.586M
YoY Change	-1864.47%	573.42%
Acquisitions
YoY Change
Other Investing Activities	$19.33M	-$30.42M
YoY Change	-256.54%	2.46%
Cash From Investing Activities	$3.785M	-$35.01M
YoY Change	-128.61%	15.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-30.58M	-$46.52M
YoY Change	-6972.13%	-220.37%
NET CHANGE
Cash From Operating Activities	53.68M	-$14.97M
Cash From Investing Activities	3.785M	-$35.01M
Cash From Financing Activities	-30.58M	-$46.52M
Net Change In Cash	26.89M	-$96.49M
YoY Change	-40.12%	-1.71%
FREE CASH FLOW
Cash From Operating Activities	$53.68M	-$14.97M
Capital Expenditures	$15.55M	$4.586M
Free Cash Flow	$38.14M	-$19.55M
YoY Change	-34.88%	-81.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001284812
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-32236
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	COHEN & STEERS, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	14-1904657
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	280 Park Avenue
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10017
CY2023Q1	dei	City Area Code CityAreaCode	212
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	832-3232
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2023Q1	dei	Trading Symbol TradingSymbol	CNS
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49117301	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	149518000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	247418000	usd
CY2023Q1	us-gaap	Investments Investments	211352000	usd
CY2022Q4	us-gaap	Investments Investments	172955000	usd
CY2023Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	76564000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	70193000	usd
CY2023Q1	us-gaap	Due From Correspondent Brokers DueFromCorrespondentBrokers	2356000	usd
CY2022Q4	us-gaap	Due From Correspondent Brokers DueFromCorrespondentBrokers	2080000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12357000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8757000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8757000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8757000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8757000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	132448000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	136430000	usd
CY2023Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	19226000	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	19049000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	19582000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	16497000	usd
CY2023Q1	us-gaap	Assets Assets	623403000	usd
CY2022Q4	us-gaap	Assets Assets	673379000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	16564000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	77764000	usd
CY2023Q1	cns	Distribution And Service Fees Payable DistributionAndServiceFeesPayable	9605000	usd
CY2022Q4	cns	Distribution And Service Fees Payable DistributionAndServiceFeesPayable	8421000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	137742000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	138809000	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	11275000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	7750000	usd
CY2023Q1	srt	Payables To Broker Dealers And Clearing Organizations PayablesToBrokerDealersAndClearingOrganizations	1223000	usd
CY2022Q4	srt	Payables To Broker Dealers And Clearing Organizations PayablesToBrokerDealersAndClearingOrganizations	835000	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	17400000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	12857000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	193809000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	246436000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Redeemable Noncontrolling Interest Equity Common Fair Value RedeemableNoncontrollingInterestEquityCommonFairValue	87249000	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Common Fair Value RedeemableNoncontrollingInterestEquityCommonFairValue	85335000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	55726960	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	55051975	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	558000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	551000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	781300000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	769373000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-165053000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-171417000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-9213000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-10784000	usd
CY2023Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	6614110	shares
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	6329178	shares
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	270610000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	250169000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	336982000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	337554000	usd
CY2023Q1	us-gaap	Nonredeemable Noncontrolling Interest NonredeemableNoncontrollingInterest	5363000	usd
CY2022Q4	us-gaap	Nonredeemable Noncontrolling Interest NonredeemableNoncontrollingInterest	4054000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	342345000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	341608000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	623403000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	673379000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	126082000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	154189000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	48857000	usd
CY2022Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	54743000	usd
CY2023Q1	us-gaap	Sponsor Fees SponsorFees	14216000	usd
CY2022Q1	us-gaap	Sponsor Fees SponsorFees	33951000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17122000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13510000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	988000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	994000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	81183000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	103198000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	44899000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	50991000	usd
CY2023Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	3216000	usd
CY2022Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	897000	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-308000	usd
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	3567000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1276000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	646000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1632000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5110000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	46531000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	56101000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10233000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9260000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	36298000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	46841000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	984000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4823000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	35314000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	42018000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.72
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.86
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.71
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.85
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49199000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48673000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49402000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49337000	shares
CY2023Q1	us-gaap	Profit Loss ProfitLoss	36298000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	46841000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	984000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4823000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	35314000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	42018000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1571000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1551000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	36885000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	40467000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.57
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.55
CY2023Q1	us-gaap	Profit Loss ProfitLoss	36298000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	46841000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	10698000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	11757000	usd
CY2023Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	1230000	usd
CY2022Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	1368000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	3982000	usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2682000	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-308000	usd
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	3567000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3369000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3486000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	117000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-974000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6254000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6307000	usd
CY2023Q1	us-gaap	Increase Decrease In Brokerage Receivables IncreaseDecreaseInBrokerageReceivables	282000	usd
CY2022Q1	us-gaap	Increase Decrease In Brokerage Receivables IncreaseDecreaseInBrokerageReceivables	59429000	usd
CY2023Q1	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	5577000	usd
CY2022Q1	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	100755000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5744000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-4024000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-61200000	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-54417000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	1184000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-260000	usd
CY2023Q1	cns	Increase Decrease In Operating Lease Liability Noncurrent IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent	-1067000	usd
CY2022Q1	cns	Increase Decrease In Operating Lease Liability Noncurrent IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent	-2984000	usd
CY2023Q1	us-gaap	Increase Decrease In Payables To Broker Dealers IncreaseDecreaseInPayablesToBrokerDealers	1184000	usd
CY2022Q1	us-gaap	Increase Decrease In Payables To Broker Dealers IncreaseDecreaseInPayablesToBrokerDealers	44760000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	3515000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	4523000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	3507000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	855000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14966000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-106449000	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	38536000	usd
CY2022Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	36478000	usd
CY2023Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	8115000	usd
CY2022Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	6787000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4586000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	681000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35007000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-30372000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	387000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	375000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	20441000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	25585000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	28101000	usd
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	26832000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	603000	usd
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2023Q1	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	2239000	usd
CY2022Q1	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	90690000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-46519000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	38648000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-96492000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-98173000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1409000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1383000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	248714000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	184373000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153631000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84817000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	149518000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	84817000	usd
CY2023Q1	cns	Cash Held In Consolidated Investment Vehicles Operating Activities CashHeldInConsolidatedInvestmentVehiclesOperatingActivities	4113000	usd
CY2022Q1	cns	Cash Held In Consolidated Investment Vehicles Operating Activities CashHeldInConsolidatedInvestmentVehiclesOperatingActivities	0	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153631000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84817000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3300000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1300000	usd
CY2023Q1	us-gaap	Dividends Share Based Compensation DividendsShareBasedCompensation	800000	usd
CY2022Q1	us-gaap	Dividends Share Based Compensation DividendsShareBasedCompensation	700000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities at the dates of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Management believes the estimates used in preparing the condensed consolidated financial statements are reasonable and prudent. Actual results could differ from those estimates.</span>
CY2023Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	164255000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	157646000	usd
CY2023Q1	us-gaap	Trading Securities Debt TradingSecuritiesDebt	47077000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	126082000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	154189000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	126082000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	154189000	usd
CY2022Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	15289000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	20000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	20000	usd
CY2023Q1	us-gaap	Investments Investments	211352000	usd
CY2022Q4	us-gaap	Investments Investments	172955000	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-2330000	usd
CY2022Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	8181000	usd
CY2023Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	2022000	usd
CY2022Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-4614000	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-308000	usd
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	3567000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-221000	usd
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	5041000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.72
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.86
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.71
CY2023Q1	us-gaap	Profit Loss ProfitLoss	36298000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	46841000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	984000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4823000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	35314000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	42018000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49199000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48673000	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	203000	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	664000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49402000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49337000	shares
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.85
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	66000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2000	shares
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.031
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.035
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.030
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.052
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.002
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.046
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.115
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.002
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.225
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.181

Files In Submission

Name	View Source	Status
cns-20230331_pre.xml	Edgar Link	unprocessable
0001284812-23-000159-index-headers.html	Edgar Link	pending
0001284812-23-000159-index.html	Edgar Link	pending
0001284812-23-000159.txt	Edgar Link	pending
0001284812-23-000159-xbrl.zip	Edgar Link	pending
cns-20230331.htm	Edgar Link	pending
cns-20230331.xsd	Edgar Link	pending
cns-20230331_g1.jpg	Edgar Link	pending
cns10q-33123ex311.htm	Edgar Link	pending
cns10q-33123ex312.htm	Edgar Link	pending
cns10q-33123ex321.htm	Edgar Link	pending
cns10q-33123ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
cns-20230331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cns-20230331_def.xml	Edgar Link	unprocessable
cns-20230331_htm.xml	Edgar Link	completed
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cns-20230331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CNS
COHEN & STEERS, INC. Stock $cns

2023 Q2 Form 10-Q Financial Statement

#000128481223000159 Filed on May 05, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNS COHEN & STEERS, INC. Stock $cns

2023 Q2 Form 10-Q Financial Statement

#000128481223000159 Filed on May 05, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNS
COHEN & STEERS, INC. Stock $cns